Safer Subxiphoid Approach for Epicardial Ablation
CardioCross™ is a minimally invasive catheter system that facilitates perforation of the atrial wall to augment separation between parietal and visceral pericardial layers via CO2 insufflation, thereby improving the safety of subxiphoid approach for epicardial access.
Clinical Need
Ventricular tachycardia (VT), is a type of cardiac arrythmia located in the ventricle causing abnormally fast heart beats. Arrythmias are caused by abnormal electrical signals due to damaged heart tissue.
The most common surgical treatment for cardiac arrythmia is ablation which involves the use of heat or radiofrequency energy to destroy small areas of heart tissue. The scarring of the tissue blocks abnormal electrical signals within the heart to restore its normal heartbeat. VT cases often require ablation on the epicardium (outer surface of the heart).
Features
0.5mmØ Perforation
The 1.5F RF Microcatheter perforation is only 0.5mm in diameter, the smallest diameter of any device currently on the market.
Outer Balloon Catheter
Provides an anchor for column strength during perforation and a datum for controlling plunge depth.
All-In-One Device
The CardioCross device is a comprehensive, over-the-wire system designed for safe perforation and inflation of the pericardial cavity. This innovative device is specifically engineered to assist in subxiphoid rendezvous procedures for ablating ventricular tachycardia, requiring only a single femoral insertion. The CardioCross device ensures precise navigation and minimizes the risk of damage during this procedure.
"With the addition of the CardioCross device to supplement the subxiphoid approach in epicardial ablations and mapping, physicians, patients, and payers alike will be pleased with the optimized workflow, decreased risk to patient safety, and cost-effective solution."​
Dr. Pasquale Santangeli
